High performance plasma amyloid-β biomarkers for Alzheimer’s disease-Reference-Cited by-同舟云学术

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Published:2018-01-31 Issue:7691 Volume:554 Page:249-254
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Nakamura Akinori,Kaneko Naoki,Villemagne Victor L.,Kato Takashi,Doecke James,Doré Vincent,Fowler Chris,Li Qiao-Xin,Martins Ralph,Rowe Christopher,Tomita Taisuke,Matsuzaki Katsumi,Ishii Kenji,Ishii Kazunari,Arahata Yutaka,Iwamoto Shinichi,Ito Kengo,Tanaka Koichi,Masters Colin L.,Yanagisawa Katsuhiko

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature25456.pdf

Reference47 articles.

1. Sevigny, J. et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 537, 50–56 (2016)

2. Sperling, R., Mormino, E. & Johnson, K. The evolution of preclinical Alzheimer’s disease: implications for prevention trials. Neuron 84, 608–622 (2014)

3. Henriksen, K. et al. The future of blood-based biomarkers for Alzheimer’s disease. Alzheimers Dement. 10, 115–131 (2014)

4. O’Bryant, S. E. et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement. 13, 45–58 (2017)

5. Rembach, A. et al. Changes in plasma amyloid β in a longitudinal study of aging and Alzheimer’s disease. Alzheimers Dement. 10, 53–61 (2014)

Cited by 1266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disposable Pipette Extraction Followed by Direct MS/MS Analysis of Beta Amyloid Peptides (Aβ38, Aβ40, and Aβ42) in Cerebrospinal Fluid Samples;Journal of the Brazilian Chemical Society;2025

2. Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer’s patients: A double-blind placebo-controlled randomized clinical trial;IBRO Neuroscience Reports;2024-12

3. The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults;Neurobiology of Aging;2024-12

4. An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer's disease diagnosis;Journal of Pharmaceutical and Biomedical Analysis;2024-11

5. Advancing Alzheimer’s biomarker Detection: A hairpin Aptamer-Based competitive electrochemical biosensor for trace Amyloid beta 40 analysis;Microchemical Journal;2024-10